Patents by Inventor Danuta Kozbor

Danuta Kozbor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190307821
    Abstract: Improved cancer therapies are provided and include methods for inhibiting growth of tumor cells in an individual by administering to the individual a polynucleotide encoding a protein that contains an immunoglobulin Fc and an antagonist peptide of a receptor expressed by tumor cells, and administering a chemotherapeutic agent to the individual, such that the growth of the tumor cells and/or metastasis of cancer cells is synergistically inhibited. Approaches are also provided for improving cancer therapies that include adoptive immunotherapies by using the polynucleotides to enhance tumor infiltration by immune cells.
    Type: Application
    Filed: November 29, 2017
    Publication date: October 10, 2019
    Inventor: Danuta KOZBOR
  • Patent number: 9296803
    Abstract: Provided are compositions and methods for inhibiting cell growth. The cells that are targeted by the compositions and methods of the invention express an antigen, a mimotope of the antigen, or a CXCR4 chemokine receptor. The method entails administering to an individual a polynucleotide encoding an immunoglobulin Fc and an antigen expressed by the cells or a mimotope of the antigen. The method also involves administering to the individual a composition which contains a polynucleotide encoding an immunoglobulin Fc and an antagonist peptide of a CXCR4 chemokine receptor expressed by the cells. Also provided are proteins encoded by the polynucleotides.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: March 29, 2016
    Assignee: Health Research, Inc.
    Inventor: Danuta Kozbor
  • Publication number: 20130011436
    Abstract: Provided are compositions and methods for inhibiting cell growth. The cells that are targeted by the compositions and methods of the invention express an antigen, a mimotope of the antigen, or a CXCR4 chemokine receptor. The method entails administering to an individual a polynucleotide encoding an immunoglobulin Fc and an antigen expressed by the cells or a mimotope of the antigen. The method also involves administering to the individual a composition which contains a polynucleotide encoding an immunoglobulin Fc and an antagonist peptide of a CXCR4 chemokine receptor expressed by the cells. Also provided are proteins encoded by the polynucleotides.
    Type: Application
    Filed: March 11, 2011
    Publication date: January 10, 2013
    Applicant: HEALTH RESEARCH, INC.
    Inventor: Danuta Kozbor
  • Patent number: 7011845
    Abstract: Liposomes encapsulating a ?-glucan have an improved activity of enhancing a cellular immunity, especially when they are transmucosally administered. Thus, the liposomes are useful for the treatment or prevention of infection or tumor.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: March 14, 2006
    Assignees: MCP Hahnemann University, Ajinomoto Co., Inc.
    Inventors: Danuta Kozbor, Yutaro Kaneko
  • Publication number: 20020182180
    Abstract: The present invention relates to methods for inducing cellular immunity against viruses which undergo mutation by introducing a mutant form of an envelope (env) glycoprotein of the virus with an altered or deleted immunodominant epitope. Also disclosed are vaccines and methods of producing the same.
    Type: Application
    Filed: May 29, 1998
    Publication date: December 5, 2002
    Inventors: YUTARO KANEKO, DANUTA KOZBOR
  • Publication number: 20020146448
    Abstract: Liposomes encapsulating a &bgr;-glucan have an improved activity of enhancing a cellular immunity, especially when they are transmucosally administered. Thus, the liposomes are useful for the treatment or prevention of infection or tumor.
    Type: Application
    Filed: May 9, 2000
    Publication date: October 10, 2002
    Inventors: Danuta Kozbor, Yutaro Kaneko
  • Patent number: 4693975
    Abstract: Somatic cell hybrids of purely human origin are described that are suitable fusion partners for producing hybridomas by fusion with antibody producing cells, which hybridomas are stable and continuous.
    Type: Grant
    Filed: November 20, 1984
    Date of Patent: September 15, 1987
    Assignee: The Wistar Institute
    Inventors: Danuta Kozbor, Carlo M. Croce